• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型半三明治型 Ru(II) 配位化合物,其特征为 fac-Ru(dmso-S)3 片段:面封基团对化学行为和体外抗癌活性的影响。

New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity.

机构信息

Department of Chemical and Pharmaceutical Sciences, Via L. Giorgieri 1, 34127, Trieste, Italy.

出版信息

Dalton Trans. 2011 Oct 7;40(37):9533-43. doi: 10.1039/c1dt11043h. Epub 2011 Aug 19.

DOI:10.1039/c1dt11043h
PMID:21853191
Abstract

The Ru(II) complex fac-[RuCl(dmso-S)(3)(dmso-O)(2)][PF(6)] (P2) was found to be an excellent precursor for the facile preparation in high yield of half sandwich-type compounds of the general formula fac-[RuCl(dmso-S)(3)(N)(2)][PF(6)] (e.g. (N)(2) = 1,2-diaminoethane (en, 4), trans-1,2-diaminocyclohexane (dach, 5), or 2 NH(3) (6)). Neutral half sandwich-type compounds of the general formula fac-[RuCl(dmso-S)(3)(N-O)] where N-O is an anionic chelating ligand (e.g. N-O = picolinate (pic, 7)) are best prepared from the universal Ru(II)-dmso precursor cis-[RuCl(2)(dmso)(4)] (P1). These complexes, that were fully characterized in solution and in the solid state, are structurally similar to the anticancer organometallic compounds [Ru(η(6)-arene)(chel)Cl]PF(6) but, in place of a face-capping arene, have the fac-Ru(dmso-S)(3) fragment. In contrast to what observed for the corresponding arene compounds, that rapidly hydrolyze the Cl ligand upon dissolution in water, compounds 4-6 are very stable and inert in aqueous solution. Probably their inertness is the reason why they showed no significant cytotoxicity against the MDA-MB-231 cancer cell line.

摘要

Ru(II) 配合物 fac-[RuCl(dmso-S)(3)(dmso-O)(2)][PF(6)](P2)被发现是一种极好的前体,可以很容易地以高产率制备半三明治型化合物,其通式为 fac-[RuCl(dmso-S)(3)(N)(2)][PF(6)](例如(N)(2)= 1,2-二乙二胺(en,4)、反式-1,2-二氨基环己烷(dach,5)或 2 NH(3)(6))。通式为 fac-[RuCl(dmso-S)(3)(N-O)]的中性半三明治型化合物,其中 N-O 是阴离子螯合配体(例如 N-O = 吡啶甲酸(pic,7))最好由通用的 Ru(II)-dmso 前体 cis-[RuCl(2)(dmso)(4)](P1)制备。这些配合物在溶液中和固态中都得到了充分的表征,它们在结构上与抗癌的有机金属化合物 [Ru(η(6)-芳烃)(chel)Cl]PF(6)相似,但取代面封端的芳烃,而是具有 fac-Ru(dmso-S)(3)片段。与相应的芳烃化合物不同,它们在水中溶解时迅速水解 Cl 配体,化合物 4-6 在水溶液中非常稳定且惰性。它们的惰性可能是它们对 MDA-MB-231 癌细胞系没有显著细胞毒性的原因。

相似文献

1
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity.新型半三明治型 Ru(II) 配位化合物,其特征为 fac-Ru(dmso-S)3 片段:面封基团对化学行为和体外抗癌活性的影响。
Dalton Trans. 2011 Oct 7;40(37):9533-43. doi: 10.1039/c1dt11043h. Epub 2011 Aug 19.
2
Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.在抗癌活性钌(II)-二甲基亚砜化合物中用二羧酸配体取代氯离子:一种可能提高活性的新策略。
Inorg Chem. 2007 Feb 5;46(3):975-92. doi: 10.1021/ic0613964.
3
New half sandwich Ru(II) coordination compounds for anticancer activity.新型半三明治型 Ru(II) 配合物的抗癌活性研究。
Dalton Trans. 2012 Jun 28;41(24):7358-71. doi: 10.1039/c2dt30654a. Epub 2012 May 11.
4
Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior.含二羧酸配体的半夹心钌II-[9]环硫烷配合物:合成、表征及化学行为
Dalton Trans. 2007 Sep 28(36):4048-58. doi: 10.1039/b707011j. Epub 2007 Aug 23.
5
Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.结构类似于具有抗肿瘤活性的有机金属钢琴凳化合物的半三明治型钌II[9]烷S3配合物:制备、结构表征及体外细胞毒性活性
J Inorg Biochem. 2008 May-Jun;102(5-6):1120-33. doi: 10.1016/j.jinorgbio.2008.01.005. Epub 2008 Jan 9.
6
Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity.用于抗癌活性的钌-卟啉缀合物的合成策略。
Dalton Trans. 2009 Dec 28(48):10742-56. doi: 10.1039/b911393b. Epub 2009 Aug 27.
7
1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity.1-(2-吡啶基)-1,2,3-三唑作为新型螯合配体用于制备具有潜在抗癌活性的钌配合物。
Dalton Trans. 2011 May 21;40(19):5188-99. doi: 10.1039/c0dt01807d. Epub 2011 Apr 5.
8
In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.涉及 6-苄基氨基嘌呤衍生物的 Ru(III) 配合物的体外和体内生物活性筛选,其促凋亡活性高于 NAMI-A。
J Inorg Biochem. 2011 Jul;105(7):937-48. doi: 10.1016/j.jinorgbio.2011.04.002. Epub 2011 Apr 12.
9
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors.阴离子配体对Ru(II)-二甲基亚砜配合物抗癌活性的影响:新的二羧酸酯化合物与它们的氯前体相比的水合动力学及体外细胞毒性
J Inorg Biochem. 2008 Apr;102(4):606-17. doi: 10.1016/j.jinorgbio.2007.10.004. Epub 2007 Oct 24.
10
The unprecedented bridging coordination mode of 1,1-cyclobutane dicarboxylate (mu-cbdc-O,O') stabilized by intramolecular hydrogen bonds in ruthenium(II) complexes.1,1-环丁烷二羧酸酯(μ-cbdc-O,O')在钌(II)配合物中通过分子内氢键稳定的前所未有的桥连配位模式。
Dalton Trans. 2005 Dec 21(24):3881-5. doi: 10.1039/b503412d. Epub 2005 Oct 3.

引用本文的文献

1
Tetra-aqua-(ethane-1,2-di-amine-κ,')nickel(II) naphthalene-1,5-di-sulfonate dihydrate.四水合(乙二胺-κ,κ')镍(II)萘-1,5-二磺酸盐二水合物
IUCrdata. 2023 Dec 14;8(Pt 12):x231032. doi: 10.1107/S2414314623010325. eCollection 2023 Dec.
2
Assessment of toxicity and genotoxic safety profile of novel fisetin ruthenium-p-cymene complex in mice.新型漆黄素-对异丙基苯钌配合物对小鼠的毒性及遗传毒性安全性评估
Toxicol Res. 2022 Dec 12;39(2):213-229. doi: 10.1007/s43188-022-00158-w. eCollection 2023 Apr.
3
Polynuclear ruthenium organometallic compounds induce DNA damage in human cells identified by the nucleotide excision repair factor XPC.
多核钌有机金属化合物通过核苷酸切除修复因子 XPC 诱导人细胞的 DNA 损伤。
Biosci Rep. 2019 Jul 15;39(7). doi: 10.1042/BSR20190378. Print 2019 Jul 31.